These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 21692270)
1. [Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period]. Dzono-Boban A; Mratović MC; Masanović M Acta Med Croatica; 2010 Dec; 64(5):453-9. PubMed ID: 21692270 [TBL] [Abstract][Full Text] [Related]
3. National program of breast cancer early detection in Brod-Posavina County (East Croatia). Jurišić I; Kolovrat A; Mitrečić D; Cvitković A Coll Antropol; 2014 Sep; 38(3):961-7. PubMed ID: 25420380 [TBL] [Abstract][Full Text] [Related]
4. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501 [TBL] [Abstract][Full Text] [Related]
5. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database. Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening. Altas H; Tureli D; Cengic I; Kucukkaya F; Aribal E; Kaya H Acta Radiol; 2016 Nov; 57(11):1304-1309. PubMed ID: 26019241 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R; J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730 [TBL] [Abstract][Full Text] [Related]
8. [Analysis for the breast cancer screening among urban populations in China, 2012-2013]. Mi ZH; Ren JS; Zhang HZ; Li J; Wang Y; Fang Y; Shi JF; Zhang K; Zhao JB; Dai M Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):887-892. PubMed ID: 27686767 [No Abstract] [Full Text] [Related]
9. Arbitration of discrepant BI-RADS 0 recalls by a third reader at screening mammography lowers recall rate but not the cancer detection rate and sensitivity at blinded and non-blinded double reading. Klompenhouwer EG; Weber RJ; Voogd AC; den Heeten GJ; Strobbe LJ; Broeders MJ; Tjan-Heijnen VC; Duijm LE Breast; 2015 Oct; 24(5):601-7. PubMed ID: 26117723 [TBL] [Abstract][Full Text] [Related]
10. [Breast cancer screening in urban Beijing, 2014-2019]. Yang L; Zhang X; Liu S; Li HC; Zhang Q; Wang N; Ji JF Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):974-980. PubMed ID: 32907288 [No Abstract] [Full Text] [Related]
11. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions. Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725 [TBL] [Abstract][Full Text] [Related]
12. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound. Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026 [TBL] [Abstract][Full Text] [Related]
13. [Performance of users in tropical areas with the BI-RADS classification of breast lesions for predicting malignancy]. Gonsu Kamga JE; Moifo B; Sando Z; Guegang Goudjou E; Nko'o Amvene S; Gonsu Fotsin J Med Sante Trop; 2013; 23(4):439-44. PubMed ID: 24334372 [TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Uematsu T; Yuen S; Kasami M; Uchida Y Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274 [TBL] [Abstract][Full Text] [Related]
15. BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis. McDonald ES; McCarthy AM; Weinstein SP; Schnall MD; Conant EF Radiology; 2017 Dec; 285(3):778-787. PubMed ID: 28715278 [TBL] [Abstract][Full Text] [Related]
16. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging. Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857 [TBL] [Abstract][Full Text] [Related]
17. A comparison between short-interval and regular-interval follow-up for BI-RADS category 3 lesions. Ruamsup S; Wiratkapun C; Wibulpolprasert B; Lertsithichai P Singapore Med J; 2010 Feb; 51(2):120-5. PubMed ID: 20358150 [TBL] [Abstract][Full Text] [Related]
18. Mammography in asymptomatic women aged 40-49 years. Silva FX; Katz L; Souza AS; Amorim MM Rev Saude Publica; 2014 Dec; 48(6):931-9. PubMed ID: 26039396 [TBL] [Abstract][Full Text] [Related]
19. Focal Breast Lesions in Clinical CT Examinations of the Chest: A Retrospective Analysis. Krug KB; Houbois C; Grinstein O; Borggrefe J; Puesken M; Hanstein B; Malter W; Maintz D; Hellmich M Rofo; 2017 Oct; 189(10):977-989. PubMed ID: 28683503 [No Abstract] [Full Text] [Related]
20. Using the BI-RADS lexicon in a restrictive form of double reading as a strategy for minimizing screening mammography recall rates. Ghate SV; Baker JA; Kim CE; Johnson KS; Walsh R; Soo MS AJR Am J Roentgenol; 2012 Apr; 198(4):962-70. PubMed ID: 22451567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]